Up­dat­ed: 'Se­mi-re­tired' an­a­lyst Ge­of­frey Porges de­parts SVB to lead fi­nances at a drug dis­cov­ery shop

Ge­of­frey Porges has end­ed his two-decade run as a biotech an­a­lyst, as the for­mer SVB Se­cu­ri­ties vice chair be­gan as CFO of Schrödinger on Thurs­day.

The long-run­ning an­a­lyst, who pre­vi­ous­ly head­ed up vac­cines mar­ket­ing at Mer­ck be­fore the turn of the mil­len­ni­um, will lead the fi­nan­cial op­er­a­tions of the 700-em­ploy­ee com­pa­ny as Schrödinger broad­ens its fo­cus from a drug dis­cov­ery part­ner to al­so build­ing out an in-house pipeline, with clin­i­cal tri­al No. 1 set to be­gin next quar­ter.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER